NEW YORK (GenomeWeb News) — Tm Bioscience shareholder will vote on Feb. 23 to decide whether Luminex will acquire the company, Tm said today.
 
Luminex said on Dec. 15 it had agreed in principle to purchase Tm in a stock-for-stock deal in which Luminex would buy a 41.5 percent stake in Tm. Luminex said it plans to deliver Tm’s kits and reagents to wider markets through its business channels.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.